Davalintide (AC-2307) is a second-generation mimetic of a pancreatic peptide hormone amylin, developed by Amylin Pharmaceuticals. In preclinical models, davalintide possessed enhanced pharmacological properties and was able to reduce food intake. Safety, tolerability, and effect on body weight of subcutaneous davalintide were investigated in obese or overweight subjects. The results of the clinical trial were not reported, but Amylin decided to discontinue davalintide in 2010.
Originator
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29711
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2105635
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
UU-52
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
DB14956
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
863919-85-1
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
71587842
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
9124
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
668U999F9T
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY | |||
|
C83650
Created by
admin on Sat Dec 16 00:36:44 GMT 2023 , Edited by admin on Sat Dec 16 00:36:44 GMT 2023
|
PRIMARY |
ACTIVE MOIETY